healthday4h
FDA Approves First Generic Liraglutide Once-Daily Injection
The U.S. Food and Drug Administration has approved the first generic referencing Victoza (liraglutide; Hikma Pharmac ...
Monthly Prescribing Reference12h
FDA Approves First Generic Version of Victoza for Type 2 Diabetes
The ongoing shortage of liraglutide injection and other GLP-1 medications prompted the FDA to prioritize the generic drug applications for these medications in order to improve patient access.
There’s still no generic Ozempic, but a lower-priced daily injected GLP-1 is coming
The US Food and Drug Administration on Monday approved a generic version of the daily injectable GLP-1 medicine liraglutide ...
ConsumerAffairs12h
FDA approves generic GLP-1 drug to treat type 2 diabetes
The U.S. Food and Drug Administration has approved the first generic version of Victoza (liraglutide injection), ...
US FDA approves Hikma's generic version of Novo's diabetes drug Victoza
The U.S. Food and Drug Administration on Monday approved Hikma Pharmaceuticals' generic version of Novo Nordisk's diabetes ...
justthenews2d
FDA approves new medication for type 2 diabetes
Patients who have a family history of medullary thyroid carcinoma and multiple endocrine neoplasia syndrome Type 2 are not ...
FDA approves generic in same class as Ozempic for diabetes. Could it ease shortage, price?
The drugs were first approved to treat type 2 diabetes – and that's what the FDA said daily injections of liraglutide could ...
Sierra Sun Times1d
FDA Approves First Generic of Once-Daily GLP-1 Injection to Lower Blood Sugar in Patients with Type 2 Diabetes
FDA Approves First Generic of Once-Daily GLP-1 Injection to Lower Blood Sugar in Patients with Type 2 Diabetes ...
The Pharma Letter2d
FDA approves first generic of Victoza
The US Food and Drug Administration (FDA) revealed on Monday that it has approved the first generic referencing Victoza ...
Managed Healthcare Executive2d
FDA Approves First Once-Daily Generic of Victoza for Type 2 Diabetes
Liraglutide injection is now approved for adult and pediatric patients ages 10 and up, proving another option amid the GLP-1 ...
New York Post3d
FDA approves Hikma’s generic version of Novo’s diabetes drug Victoza
The US Food and Drug Administration on Monday approved Hikma Pharmaceuticals’ generic version of Novo Nordisk’s diabetes drug, Victoza, clearing the way for the launch of another copy of the ...